This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Viracta Therapeutics Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Richard Trauger: Innovator in Cancer Treatment
Introduction
Richard Trauger is a notable inventor based in Cardiff, California. He has made significant contributions to the field of cancer treatment, particularly in the area of virally associated cancers. His innovative approaches have the potential to improve patient outcomes and manage side effects effectively.
Latest Patents
Richard Trauger holds a patent for "Methods of treating virally associated cancers with histone deacetylase inhibitors." This patent describes specific dosing schedules and amounts that effectively prevent and manage side effects associated with histone deacetylase inhibitor (HDACi) treatment. Additionally, these schedules may include treatment with an antiviral agent, showcasing his commitment to advancing cancer therapies.
Career Highlights
Trauger is affiliated with Viracta Therapeutics Inc., a company dedicated to developing innovative treatments for cancer. His work at this organization highlights his dedication to improving therapeutic options for patients suffering from virally associated cancers.
Collaborations
Richard Trauger has collaborated with esteemed colleagues, including Gail L Brown and Xiaohu Deng. These partnerships reflect his commitment to advancing research and development in the field of oncology.
Conclusion
Richard Trauger is a pioneering inventor whose work in cancer treatment is making a significant impact. His innovative patent and collaborations demonstrate his dedication to improving patient care and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile